ESSA Pharma Inc. (EPIX)
After hours:
| Previous close | 6.25 |
| Open | 6.25 |
| Bid | 4.38 x 200 |
| Ask | 7.57 x 200 |
| Day's range | 5.70 - 6.25 |
| 52-week range | 2.58 - 11.67 |
| Volume | |
| Avg. volume | 68,001 |
| Market cap | 252.869M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.63 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.00 |
PR NewswireESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2024.
PR NewswireESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024 at 2:30 p.m. ET in Toronto, Canada.
Simply Wall St.ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
